Article Versions Notes

Jeong S, Lee S, Kim K, Lee Y, Lee J, Oh S, Choi J-W, Kim SW, Hwang K-C, Lim S. Isoliquiritigenin Derivatives Inhibit RANKL-Induced Osteoclastogenesis by Regulating p38 and NF-κB Activation in RAW 264.7 Cells. Molecules. 2020; 25(17):3908. https://doi.org/10.3390/molecules25173908

Jeong, Seongtae, Seahyoung Lee, Kundo Kim, Yunmi Lee, Jiyun Lee, Sena Oh, Jung-Won Choi, Sang Woo Kim, Ki-Chul Hwang, and Soyeon Lim. 2020. "Isoliquiritigenin Derivatives Inhibit RANKL-Induced Osteoclastogenesis by Regulating p38 and NF-κB Activation in RAW 264.7 Cells" Molecules 25, no. 17: 3908. https://doi.org/10.3390/molecules25173908

Jeong, S., Lee, S., Kim, K., Lee, Y., Lee, J., Oh, S., Choi, J. -W., Kim, S. W., Hwang, K. -C., & Lim, S. (2020). Isoliquiritigenin Derivatives Inhibit RANKL-Induced Osteoclastogenesis by Regulating p38 and NF-κB Activation in RAW 264.7 Cells. Molecules, 25(17), 3908. https://doi.org/10.3390/molecules25173908